Home › Diffuse groot-B-cel lymfoom › Missouri › St. Louis
Diffuse groot-B-cel lymfoom klinische studies in St. Louis, MO
8 studies voor Diffuse groot-B-cel lymfoom zoeken deelnemers op locaties in en rond St. Louis (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
RekruterenFase 2
- Washington University School of Medicine - Siteman Cancer Center, St Louis
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
RekruterenFase 2
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- en nog 2
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
RekruterenFase 3
- Circuit Clinical - SSM Health Cancer Care DePaul ( Site 0166), Bridgeton · 15 mijl verwijderd
- Cancer Care Specialists of Illinois ( Site 0152), O'Fallon · 16 mijl verwijderd
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
RekruterenFase 2
- Cancer Care Specialists of Central Illinois, Swansea · 13 mijl verwijderd
CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
RekruterenFase 2
- Washington University School of Medicine, St Louis
DALY II USA/ MB-CART2019.1 for DLBCL
RekruterenFase 2
- Washington University, St. Louis, St Louis
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
RekruterenFase 2
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- en nog 2
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
RekruterenFase 2
- Siteman Cancer Center at Washington University, St Louis
Diffuse groot-B-cel lymfoom studies in andere steden
- New York City, NY21 studies
- Baldwin Park, CA19 studies
- Chicago, IL18 studies
- Houston, TX17 studies
- Los Angeles, CA17 studies
- Boston, MA16 studies
- Milwaukee, WI16 studies
- Nashville, TN15 studies
- Portland, OR15 studies
- Philadelphia, PA15 studies
- Durham, NC14 studies
- Dallas, TX13 studies
Andere studies in St. Louis
- Niet-kleincellige longkanker73 studies
- Borstkanker64 studies
- Metastatische kanker54 studies
- Colorectale kanker50 studies
- Prostaatkanker46 studies
- Kanker (alle vormen)46 studies
- Longkanker39 studies
- Eierstokkanker38 studies
- Aldermeesklierkanker33 studies
- Endometriumkanker29 studies
- Plaveiselcelcarcinoom van hoofd en hals28 studies
- Hartfalen26 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.